Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Cancer Science|February 23, 2005
Follicular lymphoma subgrouping by fluorescence in situ hybridization analysisNaohiro Sekiguchi, Yukio Kobayashi, Yukiko Yokota, et al.Biomed Research International|November 8, 2018
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q DeletionNaohiro Sekiguchi, Junko Nomoto, Akihisa Nagata, et al.Leukemia & Lymphoma|June 9, 2011
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot studyAkiyoshi Miwa, Naohiro Sekiguchi, Akira Tanimura, et al.Internal Medicine (Tokyo, Japan)|February 16, 2016
Gamma Heavy Chain Disease with T-cell Large Granular Lymphocytic Leukemia: A Case Report and Review of the LiteratureMasahide Iijima, Naohiro Sekiguchi, Akihisa Nagata, et al.International Journal of Hematology|October 7, 2005
The application of molecular analyses for primary granulocytic sarcoma with a specific chromosomal translocationNaohiro Sekiguchi, Takashi Watanabe, Yukio Kobayashi, et al.Internal Medicine (Tokyo, Japan)|December 17, 2013
Extramedullary hematopoietic pleural effusion accompanied by follicular lymphomaNaohiro Sekiguchi, Satoshi Noto, Miyuki Wagatsuma, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 26, 2004
Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slideShingo Yano, Noriko Usui, Osamu Asai, et al.BMC Cancer|October 21, 2006
Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphomaKazuki Tanimoto, Naohiro Sekiguchi, Yukiko Yokota, et al.Japanese Journal of Clinical Oncology|June 15, 2007
Primary ocular adnexal MALT lymphoma: a long-term follow-up study of 114 patientsKazuki Tanimoto, Akihiro Kaneko, Shigenobu Suzuki, et al.International Journal of Hematology|October 18, 2022
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemiaNaohiro Sekiguchi, Senji Kasahara, Toshihiro Miyamoto, et al.Pageof 6